MURRIETA, Calif., Oct. 10, 2022 /PRNewswire/ -- COPAN Diagnostics Inc. is proud to announce the second FDA clearance of Colibrí™, a semi-automated pre-analytical processor that is a complementary part ...
LOUISVILLE, CO , Nov. 03, 2021 (GLOBE NEWSWIRE) -- Colibri Heart Valve LLC, a privately held emerging medical device company, today announced the initiation of an international pilot study of the ...
MURRIETA, Calif., Jan. 29, 2024 /PRNewswire/ -- Copan Diagnostics, a leader in Clinical Microbiology automation solutions, has announced the third FDA clearance for its innovative pre-analytical ...
MURRIETA, Calif., Jan. 5, 2022 /PRNewswire/ -- COPAN Diagnostics is proud to announce the FDA clearance of Colibri™, an automated processor that is a complementary part of WASPLab®, COPAN's full ...
MEDOLLA, Italy--(BUSINESS WIRE)--Eurosets, a company based in Medolla (Italy) leader in the development, production and commercialization of advanced medical devices, announces the first patient ...
Colibrí™ system is an in vitro fully automated specimen workup platform designed to prepare MALDI-TOF ID targets and create bacterial suspensions for antibiotic susceptibility testing (AST). It ...
Copan Diagnostics, , a leading manufacturer of collection and transport systems and full laboratory automation in the world, announced that the US FDA has cleared its Colibri, an automated processor ...